Postdoctoral Fellow & Research Associate Positions - The Emily Cheng Lab
Memorial Sloan Kettering Cancer Center
Location: New York, New York
Internal Number: 60921
At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we're driving excellence and improving outcomes. We're treating cancer, one patient at a time. Join us and make a difference every day.
In compliance with applicable New York and New Jersey State regulatory authorities, COVID-19 vaccination (2 doses of either the Pfizer or Moderna vaccine or one dose of the Johnson & Johnson vaccine) is mandatory for all MSK employees, contingent workers, and volunteers. Exceptions are permitted for those employees who request and receive an approved medical or fully remote exemption.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster five months after receiving the second dose of either the Pfizer or Moderna vaccine or two months after the J&J vaccine.
Memorial Sloan Kettering Cancer Center (MSK) is one of the world's premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.
Postdoctoral fellow and research associate positions are available for highly motivated individuals interested in studying the BCL-2 family and cell death mechanisms, translating cell death mechanisms into targeted cancer therapy, interrogating the impact of cell death on tumor-immune crosstalk and immunotherapy, and exploiting immunogenic cell death to improve immunotherapy (Science 330: 1390-1393; Cancer Cell 39: 1245-1261; Nature Cancer 2022, doi: 10.1038/s43018-021-00316-3; Molecular Cell 36: 487-499; Nature Cell Biology 8: 1348-1358; Nature Cell Biology 17: 1270-1281; Nature Communications 7: 13131;). We are particularly interested in targeted therapy and immunotherapy of lung and kidney cancers.
The ideal candidate should have:
Strong background in cancer biology, immunology, and mouse models
Good publication record
Full applications including curriculum vitae and a list of three references should be submitted via email to:
Emily Cheng, M.D., Ph.D.
Member & Professor, Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, Box 20
New York, NY 10065, USA
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.